RICHARD H BOOTH
CIK 1025745 · last filed 2018-01-29
RICHARD H BOOTH is a corporate insider who has filed 38 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for THGA, was dated Jan 29, 2018. Across all open-market trades the lifetime net is −$278.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $774.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$774.6K
3
38
-$278.1K
Filer Profile
300 CADWELL DRIVE
SPRINGFIELD, MA 01104
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HANOVER INSURANCE GROUP, INC. (THGA) Delisted | Director | 8,387 | — | — | $29.1K | 6 | 2018-01-29 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | Director | 45,778 | $8.22 | $376.3K | -$141.2K | 10 | 2017-06-02 |
| NU | 50,398 | $15.37 | $774.6K | -$166.0K | 22 | 2015-01-20 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-29 | HANOVER INSURANCE GROUP, INC. (THGA) Delisted | Other (J) | — | $0 | EDGAR |
| 2017-06-02 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-17 | HANOVER INSURANCE GROUP, INC. (THGA) Delisted | Grant (A) | +1,543 | $0 | EDGAR |
| 2016-06-07 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-26 | HANOVER INSURANCE GROUP, INC. (THGA) Delisted | Grant (A) | +1,435 | $0 | EDGAR |
| 2015-06-17 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −1,000 | -$19.3K | EDGAR |
| 2015-05-21 | HANOVER INSURANCE GROUP, INC. (THGA) Delisted | Grant (A) | +1,751 | $0 | EDGAR |
| 2015-05-18 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Mixed | −1,000 | -$17.9K | EDGAR |
| 2015-04-16 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −1,000 | -$17.7K | EDGAR |
| 2015-03-17 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Sell (S) | −1,000 | -$17.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.